These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 1490766)
1. Clinical pharmacology and pharmacoepidemiology: synergistic interactions. Jones JK Int J Clin Pharmacol Ther Toxicol; 1992 Nov; 30(11):421-4. PubMed ID: 1490766 [TBL] [Abstract][Full Text] [Related]
2. Role of pharmacoepidemiology in drug development. Urquhart J Int J Clin Pharmacol Ther Toxicol; 1992 Nov; 30(11):456-8. PubMed ID: 1490779 [No Abstract] [Full Text] [Related]
3. Improving family ties: an examination of the complementary disciplines of pharmacoepidemiology and clinical pharmacology. Lehmann DF Pharmacoepidemiol Drug Saf; 2001; 10(1):63-8. PubMed ID: 11417071 [No Abstract] [Full Text] [Related]
4. The clinical pharmacist in drug research and development. Pharmacoepidemiology. Stewart RB Drug Intell Clin Pharm; 1987 Jan; 21(1 Pt 2):121-4. PubMed ID: 3816571 [TBL] [Abstract][Full Text] [Related]
5. Drug discovery and development in the age of molecular medicine. Vallance P; Levick M Clin Pharmacol Ther; 2007 Oct; 82(4):363-6. PubMed ID: 17851574 [TBL] [Abstract][Full Text] [Related]
6. [Research in the field of clinical pharmacology in the USSR]. Lakin KM; Makarov VA; Novikova NV Farmakol Toksikol; 1982; 45(3):5-12. PubMed ID: 7047211 [TBL] [Abstract][Full Text] [Related]
8. [Clinical pharmacology: current status and perspectives]. De Schaepdryver AF Verh K Acad Geneeskd Belg; 1992; 54(1):7-26. PubMed ID: 1636323 [TBL] [Abstract][Full Text] [Related]
10. Pharmacoproteomics in drug development. Witzmann FA; Grant RA Pharmacogenomics J; 2003; 3(2):69-76. PubMed ID: 12746732 [TBL] [Abstract][Full Text] [Related]
11. Relevance of pheno- and genotyping in clinical drug development. Zühlsdorf MT Int J Clin Pharmacol Ther; 1998 Nov; 36(11):607-12. PubMed ID: 9849752 [TBL] [Abstract][Full Text] [Related]
12. Is this the drug or dose for you? Impact and consideration of ethnic factors in global drug development, regulatory review, and clinical practice. Huang SM; Temple R Clin Pharmacol Ther; 2008 Sep; 84(3):287-94. PubMed ID: 18714314 [No Abstract] [Full Text] [Related]
13. Molecular medicine hones therapeutic arts to science. Waldman SA; Terzic MR; Terzic A Clin Pharmacol Ther; 2007 Oct; 82(4):343-7. PubMed ID: 17851568 [No Abstract] [Full Text] [Related]
14. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
15. Clinical pharmacology and pharmacoepidemiology: future challenges for the European Community. Royer RJ Int J Clin Pharmacol Ther Toxicol; 1992 Nov; 30(11):449-52. PubMed ID: 1490777 [No Abstract] [Full Text] [Related]
16. Simulated drug administration: an emerging tool for teaching clinical pharmacology during anesthesiology training. Struys MM; De Smet T; Mortier EP Clin Pharmacol Ther; 2008 Jul; 84(1):170-4. PubMed ID: 18431407 [TBL] [Abstract][Full Text] [Related]
17. [Gleanings from clinical pharmacology]. Káldor A Orv Hetil; 1988 Mar; 129(10):483-6. PubMed ID: 3283638 [No Abstract] [Full Text] [Related]
18. Emerging role of drug interaction studies in drug development: the good, the bad, and the unknown. Alfaro CL Psychopharmacol Bull; 2001; 35(4):80-93. PubMed ID: 12397858 [TBL] [Abstract][Full Text] [Related]
19. Benefit and risk assessment in drug development and utilization: a role for clinical pharmacology. Honig P Clin Pharmacol Ther; 2007 Aug; 82(2):109-12. PubMed ID: 17632530 [No Abstract] [Full Text] [Related]